Nurse Practitioner Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Irene Abdo

Nurse Practitioner Dallas, TX Nurse Practitioner

NPI 1679168405 CMS profile 11157231

12222 Merit Dr Ste 600, Dallas, TX 75284

Open in the dashboard

General payments

$9,846

128 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Irene Abdo of Dallas, TX is reported in the CMS Open Payments database as having received $9,846 across 128 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Nurse Practitioner profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $4,340 40
2024 General $2,599 41
2023 General $1,818 27
2022 General $1,089 20

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Irene Abdo
  • Nurse Practitioner median
  • Middle half of Nurse Practitioner
  • National median

In program year 2025, general payments to Irene Abdo were reported at $4,340. Among 41,044 Nurse Practitioner profiles paid that year, the median was $174 and the middle half received between $55 and $557.

Show as a table
Year Irene Abdo Nurse Practitioner median Middle half National median
2019 $0 $50 $22–$97 $163
2020 $0 $40 $16–$108 $114
2021 $0 $135 $40–$426 $132
2022 $1,089 $152 $48–$470 $149
2023 $1,818 $166 $54–$529 $160
2024 $2,599 $173 $55–$556 $164
2025 $4,340 $174 $55–$557 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. Penumbra, Inc. $2,416 9 payments
  2. Boston Scientific Corporation $1,258 23 payments
  3. Silk Road Medical, Inc. $850 4 payments
  4. Atricure, Inc. $847 9 payments
  5. Bolton Medical Inc $758 18 payments
  6. Endologix, Inc. $724 9 payments
  7. CVRx, Inc. $665 16 payments
  8. Abiomed $456 4 payments
  9. Aroa Biosurgery Incorporated $325 10 payments
  10. Janssen Pharmaceuticals, Inc $312 8 payments
  11. Other $1,234 18 payments

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Food and Beverage $7,685 121 payments
  2. Travel and Lodging $2,161 7 payments
Products named General payments · program years 2022–2025
  1. Indigo System $2,366 8 payments
  2. ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter $850 4 payments
  3. ENROUTE Transcarotid Stent $850 4 payments
  4. ENROUTE Transcarotid Neuroprotection System Cardiology/Vascular Diseases $850 4 payments
  5. ENROUTE Transcarotid Neuroprotection System Cardiology/Vascular Diseases $850 4 payments
  6. EkoSonic $821 16 payments
  7. Barostim Neo System $665 16 payments
  8. TREO ABDOMINAL STENT-GRAFT SYSTEM $657 16 payments
  9. ATRICLIP LAA EXCLUSION SYSTEM $403 4 payments
  10. AtriCure cryoICE cryoSPHERE Cryoablation System $386 3 payments
  11. Other $4,376 64 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

128 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record